Tafalgie Therapeutics secured €12 million in a Series A funding round with Bpifrance and the EIC FUnd
04 September 2025
04 September 2025
Total investments received (USD): 13.98M
Company: Tafalgie Therapeutics
Related deals
Lifeaz in a €13M series A round with Mutuelles Impact, BNP Paribas, GO CAPITAL, and Mirova, an affiliate of Natixis
Investments
01 February 2026
Apmonia Therapeutics raised €10M series A with Capital Grand Est, Finovam Gestion, Fondation Fournier-Majoie, Angels Santé, Capital Cell in France
Investments
09 January 2026
ErVimmune raised €17 million Series A financing with Seventure and SPRIM Global
Investments
06 January 2026
MycoPhyto raises €16M series A led by Innovacom, BNP Paribas and Bpifrance in France, joined by Noshaq, CDG Invest, Région Sud Investissement
Investments
04 January 2026
Scap Hologram raised €22m (including €11m debt) with Haventure, MinMax Medical, eCential Robotics, Surosh, business angels in France
Investments
06 October 2025
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
United Kingdom